Showing results (151-160 of 219) with videos related to
Sort By:
Pageof 22
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.Investigational New Drugs|September 15, 2010
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinomaGeorge P Kim, Michelle R Mahoney, Daniel Szydlo, et al.The Oncologist|July 19, 2018
Impact of Patient Age on Molecular Alterations of Left-Sided Colorectal TumorsAlberto Puccini, Heinz-Josef Lenz, John L Marshall, et al.Molecular Cancer Research : MCR|March 11, 2018
Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal CancersMohamed E Salem, Alberto Puccini, Axel Grothey, et al.Cancers|December 5, 2019
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine TumorsGabriel Mpilla, Amro Aboukameel, Irfana Muqbil, et al.JAMA Oncology|January 21, 2021
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical TrialDavendra P S Sohal, Mai Duong, Syed A Ahmad, et al.Annals of Surgery|August 3, 2020
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal AdenocarcinomaSyed A Ahmad, Mai Duong, Davendra P S Sohal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium studySam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2019
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Husain Yar Khan, Irfana Muqbil, et al.Targeted Oncology|March 27, 2025
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid TumorsCathy Eng, Nehal J Lakhani, Philip A Philip, et al.Pageof 22